Genetic analysis of BRCA 1 ubiquitin ligase activity and its relationship to breast cancer susceptibility

Department of Medical and Molecular Genetics, Kings College London School of Medicine at Guy’s, Kings and St Thomas’ Hospitals, London, UK, Medical Research Council Virology Unit, Glasgow G11 5JR, Scotland, UK, Present address, Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan and Institute for Structural Molecular Biology and School of Crystallography, Birkbeck College, University of London, London WC1E 7HX, UK

[1]  L. Starita,et al.  Centrosomal Microtubule Nucleation Activity Is Inhibited by BRCA1-Dependent Ubiquitination , 2005, Molecular and Cellular Biology.

[2]  R. Mayer,et al.  Ubiquitin and ubiquitin-like proteins as multifunctional signals , 2005, Nature Reviews Molecular Cell Biology.

[3]  A. Zharkikh,et al.  Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral , 2005, Journal of Medical Genetics.

[4]  Junjie Chen,et al.  BRCA1 participates in DNA decatenation , 2005, Nature Structural &Molecular Biology.

[5]  A. Horwitz,et al.  BRCA1/BARD1 Ubiquitinate Phosphorylated RNA Polymerase II* , 2005, Journal of Biological Chemistry.

[6]  C. Dominguez,et al.  Solution structure of the ubiquitin-conjugating enzyme UbcH5B. , 2004, Journal of molecular biology.

[7]  W. Foulkes,et al.  BRCA1 and BRCA2: 1994 and beyond , 2004, Nature Reviews Cancer.

[8]  A. Zharkikh,et al.  Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation , 2004, Journal of Medical Genetics.

[9]  E. Solomon,et al.  BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. , 2004, Human molecular genetics.

[10]  L. Forétova,et al.  BRCA1 and BRCA2 mutations in women with familial or early‐onset breast/ovarian cancer in the Czech Republic , 2004, Human mutation.

[11]  T. Ohta,et al.  Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Tony Hunter,et al.  Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein* , 2003, The Journal of Biological Chemistry.

[13]  B. Henderson,et al.  Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. , 2003, Experimental cell research.

[14]  C. Vandenberg,et al.  Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains , 2002, The EMBO journal.

[15]  N. Keep,et al.  Identification of Residues Required for the Interaction of BARD1 with BRCA1* , 2002, The Journal of Biological Chemistry.

[16]  C. Boutell,et al.  Herpes Simplex Virus Type 1 Immediate-Early Protein ICP0 and Its Isolated RING Finger Domain Act as Ubiquitin E3 Ligases In Vitro , 2002, Journal of Virology.

[17]  M. King,et al.  BRCA1 RING Domain Cancer-predisposing Mutations , 2001, The Journal of Biological Chemistry.

[18]  D. Livingston,et al.  Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Rachel E. Klevit,et al.  Structure of a BRCA1–BARD1 heterodimeric RING–RING complex , 2001, Nature Structural Biology.

[20]  Q. Wang,et al.  Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1 , 2001, Oncogene.

[21]  N. Janin,et al.  The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript , 2001, Human mutation.

[22]  T. Ohta,et al.  The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation* , 2001, The Journal of Biological Chemistry.

[23]  M. Erdos,et al.  Role of direct interaction in BRCA1 inhibition of estrogen receptor activity , 2001, Oncogene.

[24]  Y. Houvras,et al.  BRCA1 Physically and Functionally Interacts with ATF1* , 2000, The Journal of Biological Chemistry.

[25]  Ping Wang,et al.  Structure of a c-Cbl–UbcH7 Complex RING Domain Function in Ubiquitin-Protein Ligases , 2000, Cell.

[26]  H. Ruffner,et al.  CBP/p300 interact with and function as transcriptional coactivators of BRCA1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Keith D Wilkinson,et al.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression , 1998, Oncogene.

[28]  C. Mathew,et al.  Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer , 1998, Genes, chromosomes & cancer.

[29]  Anne M. Bowcock,et al.  Identification of a RING protein that can interact in vivo with the BRCA1 gene product , 1996, Nature Genetics.

[30]  H. Shih,et al.  A positive genetic selection for disrupting protein-protein interactions: identification of CREB mutations that prevent association with the coactivator CBP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Joshua E. Elias,et al.  BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. , 2004, Molecular and cellular biology.

[32]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.